EUVIMEDEUVIMED entdecken
Crossref

Downregulation of PAX1 in OSCC Enhances Stemness and Immunosuppression via IFIT1 and PD ‐ L1 Pathways

Hui-Hsin Ko, Hsin-Hui Peng, Han-Yi E Chou, Hsin-Han Hou, Wei-Wen Liu, Mark Yen-Ping Kuo, Alan Yueh-Luen Lee, Hsiang-Fong Kao, Hung-Ying Lin, Ying-Chieh Chang, Wei-Ting Kuo, Shih-Jung Cheng iD

Oral Diseases · 2025

DOI: 10.1111/odi.15225 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oral Diseases, 2025. Verfasst von Hui-Hsin Ko und 11 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Clinical Dentistry, School of Dentistry, National Taiwan University, Taipei, Taiwan. Hauptthemen laut MEDLINE: B7-H1 Antigen, Mouth Neoplasms, Neoplastic Stem Cells, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Ministry of Science and Technology, Taipei, Taiwan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Our study investigated how arecoline‐induced extracellular vesicle (EV) secretion suppresses PAX1 protein production through DNA hypermethylation and examined whether PAX1 downregulation enhances cancer stemness and immunosuppression in the tumor microenvironment. Materials and Methods EVs were isolated from SAS/TW2.6 cancer cell lines using ultracentrifugation and identified using transmission electron microscopy. PAX1 DNA methylation was tested in an ISO17025‐certified lab, with and without EV pretreatment. Stemness and epithelial–mesenchymal transition markers were assessed by western blotting and 3D culture. PAX1, IFIT1, and PD‐L1 co‐expression were examined through immunofluorescence. Flow cytometry detected various T cells.

Results

Arecoline‐induced EVs enhanced PAX1 methylation, suppressing its tumor‐suppressive function. Reduced PAX1 mRNA in OSCCs was linked to larger tumors, nodal metastasis, late‐stage disease, areca quid chewing, and poor survival. Downregulated PAX1 protein negatively correlated with IFIT1 and PD‐L1 expression. Reduced PAX1 promoted stemness via the IFIT1 pathway, increasing PD‐L1 secretion and aiding immune evasion. PD‐L1 expression correlated with Treg and CD8+ T cell levels in OSCC tissues, and the CD4+/CD8+ T cell ratio was lower in OSCC patients than in controls.

Conclusion

Arecoline‐induced EV production, which influences PAX1/IFIT1/PD‐L1 function, may serve as a reliable biomarker for targeted therapy in OSCC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7-H1 AntigenMouth NeoplasmsNeoplastic Stem CellsCarcinoma, Squamous CellHumansDown-RegulationCell Line, TumorAdaptor Proteins, Signal TransducingExtracellular VesiclesArecolineDNA MethylationTumor MicroenvironmentEpithelial-Mesenchymal TransitionRNA-Binding ProteinsMaleFemalePaired Box Transcription Factors

Stichwörter der Autor:innen

IFIT1PAX1PD‐Lextracellular vesicles (EVs)immunosuppressionoral squamous cell carcinoma (OSCC)

Substanzen

B7-H1 AntigenCD274 protein, humanPAX1 transcription factorAdaptor Proteins, Signal TransducingArecolineRNA-Binding ProteinsPaired Box Transcription Factors

Autor:innen und Institutionen

  • Graduate Institute of Clinical Dentistry, School of Dentistry, National Taiwan University, Taipei, Taiwan.
  • School of Dentistry, National Taiwan University, Taipei, Taiwan.
  • Department of Dentistry, College of Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Department of Dentistry, National Taiwan University Hospital Hsin-Chu Branch, Hsin-Chu, Taiwan.
  • Graduate Institute of Oral Biology, School of Dentistry, National Taiwan University, Taipei, Taiwan.
  • National Institute of Cancer Research, National Health Research Institutes, Zhunan, Taiwan.

ORCID-Profile: Shih-Jung Cheng

Förderung

  • Ministry of Science and Technology, Taipei, Taiwan

Zitieren

APA

Ko, H. H., Peng, H. H., Chou, H. E., Hou, H. H., Liu, W. W., Kuo, M. Y., Lee, A. Y., Kao, H. F., Lin, H. Y., Chang, Y. C., Kuo, W. T., & Cheng, S. J. (2025). Downregulation of PAX1 in OSCC Enhances Stemness and Immunosuppression via IFIT1 and PD ‐ L1 Pathways. Oral Diseases. https://doi.org/10.1111/odi.15225

Vancouver

Ko HH, Peng HH, Chou HE, Hou HH, Liu WW, Kuo MY, et al. Downregulation of PAX1 in OSCC Enhances Stemness and Immunosuppression via IFIT1 and PD ‐ L1 Pathways. Oral Diseases. 2025. doi:10.1111/odi.15225

BibTeX
@article{Ko2025,
  author = {Ko, Hui-Hsin and Peng, Hsin-Hui and Chou, Han-Yi E and Hou, Hsin-Han and Liu, Wei-Wen and Kuo, Mark Yen-Ping and Lee, Alan Yueh-Luen and Kao, Hsiang-Fong and Lin, Hung-Ying and Chang, Ying-Chieh and Kuo, Wei-Ting and Cheng, Shih-Jung},
  title = {Downregulation of PAX1 in OSCC Enhances Stemness and Immunosuppression via IFIT1 and PD ‐ L1 Pathways},
  journal = {Oral Diseases},
  year = {2025},
  doi = {10.1111/odi.15225}
}
Kostenlos starten →